Equity Overview
Price & Market Data
Price: $0.168
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $23,315,761
Daily Volume: 0
Performance Metrics
1 Week: 3.18%
1 Month: -4.17%
3 Months: -4.22%
6 Months: -14.58%
1 Year: -36.06%
YTD: -4.22%
Details
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.